Question 1

What is the catalog number for LRFN3 (Leucine-rich Repeat and Fibronectin Type-III Domain-containing Protein 3, Synaptic Adhesion-like Molecule 4, SALM4, UNQ5865/PRO34192) discontinued?

Accepted Answer

The catalog number for LRFN3 (Leucine-rich Repeat and Fibronectin Type-III Domain-containing Protein 3, Synaptic Adhesion-like Molecule 4, SALM4, UNQ5865/PRO34192) discontinued is S9111-06.

Question 2

What sizes are available for LRFN3 (Leucine-rich Repeat and Fibronectin Type-III Domain-containing Protein 3, Synaptic Adhesion-like Molecule 4, SALM4, UNQ5865/PRO34192) discontinued?

Accepted Answer

LRFN3 (Leucine-rich Repeat and Fibronectin Type-III Domain-containing Protein 3, Synaptic Adhesion-like Molecule 4, SALM4, UNQ5865/PRO34192) discontinued is available in the following size(s): 50 µg.

Question 3

Is LRFN3 (Leucine-rich Repeat and Fibronectin Type-III Domain-containing Protein 3, Synaptic Adhesion-like Molecule 4, SALM4, UNQ5865/PRO34192) discontinued in stock?

Accepted Answer

LRFN3 (Leucine-rich Repeat and Fibronectin Type-III Domain-containing Protein 3, Synaptic Adhesion-like Molecule 4, SALM4, UNQ5865/PRO34192) discontinued

Selected Variant

S9111-06

Size: 50 µg

Product Specifications

Clonality

Pab

Question 4

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 5

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 6

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.